Showing results (241-250 of 322) with videos related to

Sort By:
Pageof 33
JAMA Oncology|July 17, 2015
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical TrialAnimesh Pardanani, Claire Harrison, Jorge E Cortes, et al.
Blood Advances|May 31, 2022
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosisAndreas Reiter, Juliana Schwaab, Daniel J DeAngelo, et al.
Haematologica|June 22, 2023
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemiaFrancesco Mannelli, Matteo Piccini, Sara Bencini, et al.
Blood Advances|December 21, 2021
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 studyJohn Mascarenhas, Francesco Passamonti, Kate Burbury, et al.
Blood|May 10, 2007
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelAyalew Tefferi, Juergen Thiele, Attilio Orazi, et al.
British Journal of Haematology|May 16, 2013
Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapyClaire N Harrison, Ruben A Mesa, Jean-Jacques Kiladjian, et al.
Blood|June 4, 2008
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemiaAlessandro M Vannucchi, Elisabetta Antonioli, Paola Guglielmelli, et al.
Leukemia|December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patientsGiacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
American Journal of Hematology|May 11, 2012
Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: an international study of 264 patientsVeronika Buxhofer-Ausch, Heinz Gisslinger, Jürgen Thiele, et al.
Blood Advances|May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosisAaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Pageof 33